Patient Reported Outcomes With WaveLight LASIK

NCT ID: NCT06668909

Last Updated: 2025-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-01

Study Completion Date

2025-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a multi-site, single-arm, ambispective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed 12+ months post-operatively. Clinical evaluations will include administration of the OSDI, modified PROWL, and dry eye questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WaveLight® EX500

Phorcidies Planned Contoura LASIK

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Wavefront Optimized or Phorcidies Planned Contoura LASIK for myopia or myopic astigmatism 12 to 15 months ago
* Age: 21 to 35 years of age at the time of surgery.
* Preoperative myopic sphere of -1.00 D to -8.00 D
* Preoperative regular astigmatism of 0.00 D to -3.00 D.
* Stable refraction preoperatively defined as \< 0.5 D of change over at least 1 year.
* Refractive target of bilateral emmetropia.

Exclusion Criteria

* Corneal ectatic disorders.
* Patients with a calculated residual stromal depth of \< 300 um.
* Pre-existing retinal or corneal pathology, or irregular astigmatism.
* Pre-existing autoimmune diseases, dry eye, glaucoma, diabetes, etc.
* Previous corneal surgeries prior to LASIK.
* LASIK enhancements.
Minimum Eligible Age

21 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sengi

INDUSTRY

Sponsor Role collaborator

OVO LASIK + Lens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NVISION Eye Centers

San Diego, California, United States

Site Status

Boston Vision

Brookline, Massachusetts, United States

Site Status

Ovo Lasik + Lens

Saint Louis Park, Minnesota, United States

Site Status

Mann Eye Institute

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ML-24-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Odyssey Evaluation in Post LASIK Patients
NCT07260695 RECRUITING PHASE4
CONTOURA vs WFO Ablation PRK & LASIK
NCT05037370 RECRUITING NA